Discordant repolarization alternans-induced atrial fibrillation is suppressed by verapamil

Circulation Journal

Volumn 69, Issue 11, 2005, Pages 1368-1373

  Hiromoto, Kenji ^a   Shimizu, Hiroki ^a,b   Furukawa, Yoshio ^a   Kanemori, Tetsuzou ^a   Mine, Takanao ^b   Masuyama, Tohru ^b   Ohyanagi, Mitsumasa ^a  

^a Division of Coronary Heart Disease   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Spatiotemporal repolarization; Verapamil

Indexed keywords

VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCORDANT HEART REPOLARIZATION ALTERANS; DRUG EFFECT; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CATHETER; HEART CYCLE; HEART DISEASE; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HUMAN; MALE;

ACTION POTENTIALS; ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR FIBRILLATION; VERAPAMIL;

EID: 27644522688     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1368     Document Type: Article

References (25)

1. Hashimoto H, Asano M, Nakashima M. Alternation in refractoriness and in conduction delay in the ischemic myocardium associated with the alternation in the ST-T complex during acute coronary occlusion in anesthetized dogs. J Electrocardiol 1986; 19: 77 - 84.
2. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994; 330: 235 - 241.
3. Estes NA 3rd, Michaud G, Zipes DP, El-Sherif N, Venditti FJ, Rosenbaum DS, et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997; 80: 1314 - 1318.
4. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation 1999; 99: 1385 - 1394.
5. Adam DR, Smith JM, Akselrod S, Nyberg S, Powell AO, Cohen RJ. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol 1984; 17: 209 - 218.
6. Chang CM, Wu TJ, Zhou S, Doshi RN, Lee MH, Ohara T, et al. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation 2001; 103: 22 - 25.
7. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92: 1954 - 1968.
8. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998; 98: 2202 - 2209.
9. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997; 96: 4027 - 4035.
10. Niwano S, Wakisaka Y, Kojima J, Yumoto Y, Inuo K, Hara H, et al. Monitoring the progression of the atrial electrical remodeling in patients with paroxysmal atrial fibrillation. Circ J 2003; 67: 133 - 138.
11. Lee SH, Yu WC, Cheng JJ, Hung CR, Ding YA, Chang MS, et al. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 2000; 101: 200 - 206.
12. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: Time course and mechanisms. Circulation 1996; 94: 2968 - 2974.
13. Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997; 95: 1945 - 1953.
14. Daoud EG, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997; 96: 1542 - 1550.
15. Hirayama Y, Saitoh H, Atarashi H, Hayakawa H. Electrical and mechanical alternans in canine myocardium in vivo: Dependence on intracellular calcium cycling. Circulation 1993; 88: 2894 - 2902.
16. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation: Current understandings and research imperatives. J Am Coll Cardiol 1993; 22: 1830 - 1834.
17. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995; 155: 469 - 473.
18. Rosenbaum DS, Albrecht P, Cohen RJ. Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: Promise and pitfalls (Review). J Cardiovasc Electrophysiol 1996; 7: 1095 - 1111.
19. Pastore JM, Rosenbaum DS. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res 2000; 87: 1157 - 1163.
20. Kim BS, Kim YH, Hwang GS, Pak HN, Lee SC, Shim WJ, et al. Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol 2002; 39: 1329 - 1336.
21. Ramanna H, Elvan A, Wittkampf FH, de Bakker JM, Hauer RN, Robles de Medina EO. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J Am Coll Cardiol 2001; 37: 1403 - 1407.
22. Narayan SM, Bode F, Karasik PL, Franz MR. Alternans of atrial action potentials during atrial flutter as a precursor to atrial fibrillation. Circulation 2002; 106: 1968 - 1973.
23. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988; 62: 403 - 407.
24. Kinebuchi O, Mitamura H, Shiroshita-Takeshita A, Kurita Y, Ieda M, Ohashi N, et al. Oral verapamil attenuates the progression of pacinginduced electrical and mechanical remodeling of the atrium. Circ J 2004; 68: 494 - 500.
25. Hirata Y, Kodama I, Iwamura N, Shimizu T, Toyama J, Yamada K. Effects of verapamil on canine Purkinje fibers and ventricular muscle fibers with particular reference to the alternation of action potential duration after a sudden increase in driving rate. Cardiovasc Res 1979; 13: 1-8.